SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-K’ for 9/30/16 – ‘EX-3.1’

On:  Thursday, 12/22/16, at 5:04pm ET   ·   For:  9/30/16   ·   Accession #:  1615774-16-9049   ·   File #:  1-35527

Previous ‘10-K’:  ‘10-K’ on 1/5/16 for 9/30/15   ·   Next:  ‘10-K’ on 12/29/17 for 9/30/17   ·   Latest:  ‘10-K’ on 3/31/23 for 12/31/22   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/22/16  Emmaus Life Sciences, Inc.        10-K        9/30/16   71:6.7M                                   S2 Filings LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    882K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML    105K 
 3: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     35K 
 4: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     51K 
 5: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     50K 
 6: EX-10.23    Material Contract                                   HTML     35K 
 7: EX-10.24    Material Contract                                   HTML     59K 
 8: EX-21.1     Subsidiaries List                                   HTML     17K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     19K 
10: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
11: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
13: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
20: R1          Document and Entity Information                     HTML     49K 
21: R2          Consolidated Balance Sheets                         HTML    110K 
22: R3          Consolidated Balance Sheets (Parenthetical)         HTML     40K 
23: R4          Consolidated Statements of Operations               HTML     70K 
24: R5          Consolidated Statements of Changes in               HTML     63K 
                Stockholders' Deficit                                            
25: R6          Consolidated Statements of Cash Flows               HTML    100K 
26: R7          Nature of Operations                                HTML     41K 
27: R8          Summary of Significant Accounting Policies          HTML     66K 
28: R9          Convertible Debt and Equity Financings              HTML    136K 
29: R10         Derivative Liabilities                              HTML     59K 
30: R11         Stockholders' Deficit                               HTML    127K 
31: R12         Income Taxes                                        HTML     45K 
32: R13         Related Party Transactions                          HTML     40K 
33: R14         Loss Per Share                                      HTML     36K 
34: R15         Commitments and Contingent Liabilities              HTML     55K 
35: R16         Significant Customers                               HTML     25K 
36: R17         Subsequent Events                                   HTML     41K 
37: R18         Summary of Significant Accounting Policies          HTML    125K 
                (Policies)                                                       
38: R19         Summary of Significant Accounting Policies          HTML     28K 
                (Tables)                                                         
39: R20         Convertible Debt and Equity Financings (Tables)     HTML    114K 
40: R21         Derivative Liabilities (Tables)                     HTML     50K 
41: R22         Stockholders' Deficit (Tables)                      HTML    103K 
42: R23         Income Taxes (Tables)                               HTML     43K 
43: R24         Loss Per Share (Tables)                             HTML     33K 
44: R25         Commitments and Contingent Liabilities (Tables)     HTML     34K 
45: R26         Nature of Operations (Details Narrative)            HTML     62K 
46: R27         Summary of Significant Accounting Policies          HTML     30K 
                (Details)                                                        
47: R28         Summary of Significant Accounting Policies          HTML     75K 
                (Details Narrative)                                              
48: R29         Convertible Debt and Equity Financings (Details)    HTML    110K 
49: R30         Convertible Debt and Equity Financings (Details     HTML    105K 
                Narrative)                                                       
50: R31         Derivative Liabilities (Details)                    HTML     30K 
51: R32         Derivative Liabilities (Details 1)                  HTML     57K 
52: R33         Derivative Liabilities (Details Narrative)          HTML     86K 
53: R34         Stockholders' Deficit (Details)                     HTML     28K 
54: R35         Stockholders' Deficit (Details 1)                   HTML     42K 
55: R36         Stockholders' Deficit (Details 2)                   HTML    100K 
56: R37         Stockholders' Deficit (Details 3)                   HTML     45K 
57: R38         Stockholders' Deficit (Details 4)                   HTML     50K 
58: R39         Stockholders' Deficit (Details Narrative)           HTML    203K 
59: R40         Stockholders' Deficit (Details Narrative 1)         HTML     55K 
60: R41         Income Taxes (Details)                              HTML     37K 
61: R42         Income Taxes (Details 1)                            HTML     42K 
62: R43         Income Taxes (Details Narrative)                    HTML     25K 
63: R44         Related Party Transactions (Details Narrative)      HTML     88K 
64: R45         Loss Per Share (Details)                            HTML     39K 
65: R46         Commitments and Contingent Liabilities (Details)    HTML     56K 
66: R47         Commitments and Contingent Liabilities (Details     HTML    107K 
                Narrative)                                                       
67: R48         Significant Customers (Details Narrative)           HTML     30K 
68: R49         Subsequent Events (Details Narrative)               HTML    109K 
70: XML         IDEA XML File -- Filing Summary                      XML    111K 
69: EXCEL       IDEA Workbook of Financial Reports                  XLSX     89K 
14: EX-101.INS  XBRL Instance -- myan-20160930                       XML   2.01M 
16: EX-101.CAL  XBRL Calculations -- myan-20160930_cal               XML    143K 
17: EX-101.DEF  XBRL Definitions -- myan-20160930_def                XML    731K 
18: EX-101.LAB  XBRL Labels -- myan-20160930_lab                     XML   1.10M 
19: EX-101.PRE  XBRL Presentations -- myan-20160930_pre              XML    922K 
15: EX-101.SCH  XBRL Schema -- myan-20160930                         XSD    169K 
71: ZIP         XBRL Zipped Folder -- 0001615774-16-009049-xbrl      Zip    163K 


‘EX-3.1’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 3.1

 

CERTIFICATE OF AMENDMENT OF
CERTIFICATE OF INCORPORATION OF
MYND ANALYTICS, INC.

 

MYnd Analytics, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify:

 

FIRST: That at a meeting of the Board of Directors (the “Board”) of MYnd Analytics, Inc. (formerly known as CNS Response, Inc.) (the “Corporation”) on September 2, 2015, resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation (the “Charter”) approving of a reverse stock split by a ratio of not less than 1-for-10 and not more than 1-for-200 (the “Range”), as determined at the sole discretion of the Board (the “Reverse Split”), and, declaring said amendment (hereinafter the “Amendment”), to be advisable and calling for consent of the stockholders of the Corporation for consideration thereof. The resolutions setting forth the proposed Amendment is substantially as follows:

 

RESOLVED, that the Board declares it advisable and in the best interests of the Corporation to amend the Charter to effect the Reverse Split, at a ratio with the Range, as determined by the Board, at its discretion; and be it further

 

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating Article IV thereof relating to the capital stock of the Corporation, so that, as amended and restated, Article IV shall be and read in its entirety, as follows:

 

"ARTICLE IV

 

CAPITAL STOCK

 

The amount of total authorized capital stock of this Corporation is Five Hundred Thousand Dollars ($500,000) divided into 500,000,000 shares of $0.001 par value each. All shares shall be designated as Common Stock. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Company’s Common Stock.

 

Upon the effectiveness of the amendment to the Certificate of Incorporation adding this paragraph thereto (the “Effective Time”), each 200 shares of outstanding Common Stock, par value $0.001 per share (for purposes of this Article IV “Old Common Stock”), of the Corporation issued and outstanding immediately prior to the Effective Time shall be, without any action of the holder thereof, automatically combined into one (1) validly issued, fully paid and non-assessable share of Common Stock, par value $0.001 per share (for purposes of this Article IV, the “New Common Stock”) of the Corporation (the “Reverse Split”). Each stock certificate that, immediately prior to the Effective Time, represented shares of Old Common Stock shall, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares of New Common Stock into which the shares of Old Common Stock represented by such certificate shall have been combined. No fractional shares of Common Stock will be issued as a result of the Reverse Split. In the event the Reverse Split leaves a stockholder with a fraction of a share, the number of shares due to the stockholder shall be rounded up. For example, if the Reverse Split leaves an individual stockholder with one and one half shares, the stockholder will be issued, post Reverse Split, two whole shares."

 

SECOND: That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of the Corporation was duly called and held on October 28, 2015 upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.

 

THIRD: That said Amendment was duly adopted on August 24, 2016 in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

FOURTH: That the capital of said Corporation shall not be reduced under or by reason of said Amendment.

FIFTH: The foregoing Amendment shall be effective as of September 21, 2016, at 8:00 a.m. Eastern Time.

 

SIXTH: Except as set forth in this Amendment, the Certificate of Incorporation, as previously amended, remains in full force and effect.

 

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of the Certificate of Incorporation of MYnd Analytics, Inc. as of September 19, 2016.

 

MYND ANALYTICS, INC.

 

By: /s/ George Carpenter  
Name:  George Carpenter  
Title: President  

 

 C: 
  C: 1 

 

 

CERTIFICATE OF AMENDMENT OF

CERTIFICATE OF INCORPORATION OF

CNS RESPONSE, INC.

 

CNS Response, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

 

FIRST: That at a meeting of the Board of Directors (the "Board") of CNS Response, Inc. (the "Corporation") on September 2, 2015, resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation:(i) approving of an increase in the number of authorized shares which the Corporation is authorized to issue from 180,000,000 to 500,000,000 (the "Share Increase"), and (ii) approving the change of the Corporation's name from CNS Response, Inc. to MYnd Analytics, Inc., and, declaring said amendments, as reflected in a single amendment (hereinafter the "Amendment"), to be advisable and calling for separate approvals of the stockholders of the Corporation for consideration thereof.  The resolutions setting forth the proposed Amendment are substantially as follows:

 

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating the Article I thereof relating to the name change of the Corporation, so that, as amended and restated, Article I shall be and read in its entirety, as follows:

 

ARTICLE I

 

The name of the Corporation is MYnd Analytics, Inc.

 

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating the Article IV thereof relating to the authorized shares of the Corporation, so that, as amended and restated, Article IV shall be and read in its entirety, as follows:

 

ARTICLE IV

 

CAPITAL STOCK

 

Section 4.A. The total number of shares of stock which the Corporation shall have authority to issue is Five Hundred Fifteen Million (515,000,000).

 

Section 4.B. Common Stock. The total number of shares of common stock which the Corporation shall have authority to issue is Five Hundred Million (500,000,000) shares, with a par value of $0.001 per share. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Corporation's Common Stock.

 

Section 4.C. Blank-Check Preferred Stock. The total number of shares of undesignated preferred stock which the Corporation shall have the authority to issue is Fifteen Million (15,000,000) shares, with a par value of $0.001 per share. The Board of Directors is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.

 

SECOND: That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of the Corporation was duly called and held on October 28, 2015 upon notice in accordance with section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.

 

THIRD: That said Amendment was duly adopted on October 28, 2015 in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

FOURTH:   That the capital of said Corporation shall not be reduced under or by reason of said Amendment.

 

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of the Certificate of Incorporation of CNS Response, Inc. as of November 2, 2015.

 

CNS RESPONSE, INC.  
     
By:  /s/ George C. Carpenter IV  
Name: George C. Carpenter IV  
Title: President & Chief Executive Officer  

 

 C: 
 2 

 

 

CERTIFICATE OF AMENDMENT OF

CERTIFICATE OF INCORPORATION OF

CNS RESPONSE, INC.

 

CNS Response, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

 

FIRST: That at a meeting of the Board of Directors (the “Board”) of CNS Response, Inc. (the “Corporation”) on March 26, 2013, resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation: (i) approving of an increase in the number of authorized shares which the Corporation is authorized to issue from 100,000,000 to 150,000,000 (the “Share Increase”), and (ii) authorizing 15,000,000 shares of a new class of preferred stock, par value $0.001 per share (the “Preferred Authorization”), and, declaring said amendments, as reflected in a single amendment (hereinafter the “Amendment”), to be advisable and calling for separate approvals of the stockholders of the Corporation for consideration thereof.  The resolution setting forth the proposed Amendment is substantially as follows:

 

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating the Article IV thereof relating to the authorized shares of the Corporation, so that, as amended, said Article IV shall be and read in its entirety, as follows:

 

ARTICLE IV

 

CAPITAL STOCK

 

Section 4.A. The total number of shares of stock which the Corporation shall have authority to issue is One Hundred Sixty Five Million (165,000,000).

 

Section 4.B. Common Stock. The total number of shares of common stock which the Corporation shall have authority to issue is One Hundred Fifty Million (150,000,000) shares, with a par value of $0.001 per share. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Corporation’s common stock.

 

Section 4.C. Blank-Check Preferred Stock. The total number of shares of undesignated preferred stock which the Corporation shall have the authority to issue is Fifteen Million (15,000,000) shares, with a par value of $0.001 per share. The Board of Directors is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.

 

SECOND: That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of the Corporation was duly called and held on May 23, 2013 upon notice in accordance with section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.

 

THIRD: That said Amendment was duly adopted on May 23, 2013 in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

FOURTH:   That the capital of said Corporation shall not be reduced under or by reason of said Amendment.

 

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of the Certificate of Incorporation of CNS Response, Inc. as of May 31, 2013.

 

CNS RESPONSE, INC.  
     
By:  /s/ George Carpenter  
Name: George C. Carpenter IV  
Title: Chief Executive Officer  

 

 C: 
 3 

 

 

CERTIFICATE OF AMENDMENT OF

CERTIFICATE OF INCORPORATION OF

CNS RESPONSE, INC.

 

CNS Response, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

 

FIRST: That, by unanimous written consent in lieu of a meeting of the Board of Directors (the “Board”) of CNS Response, Inc. (the “Corporation”), resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation: (i) approving of a change to the number of authorized shares which the Corporation is authorized to issue, and (ii) approving of a reverse stock split on a 1 for 10, 1 for 20, 1 for 30, 1 for 40, or 1 for 50 basis, as determined at the sole discretion of the Board (the “Reverse Split”), and, declaring said amendments, as reflected in a single amendment (hereinafter the “Amendment”), to be advisable and calling for consent of the stockholders of the Corporation for consideration thereof.  The resolution setting forth the proposed Amendment is substantially as follows:

 

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating the Article IV thereof relating to the authorized shares of the Corporation, so that, as amended, said Article IV shall be and read in its entirety, as follows:

 

ARTICLE IV

 

CAPITAL STOCK

 

“The amount of total authorized capital stock of this Corporation is One Hundred Thousand Dollars ($100,000) divided into 100,000,000 shares of $0.001 par value each. All shares shall be designated as common stock. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Corporation’s common stock.

 

On April 2, 2012, at 5:00 p.m. Pacific Time (the “Effective Time”), each thirty (30) shares of outstanding common stock, par value $0.001 per share (for purposes of this Article IV “Old Common Stock”), of the Corporation issued and outstanding immediately prior to the Effective Time shall be, without any action of the holder thereof, automatically combined into one (1) validly issued, fully paid and non-assessable share of common stock, par value $0.001 per share (for purposes of this Article IV, the “New Common Stock”) of the Corporation.  Each stock certificate that, immediately prior to the Effective Time, represented shares of Old Common Stock shall, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares of New Common Stock into which the shares of Old Common Stock represented by such certificate shall have been combined.  No fractional shares of Common Stock will be issued as a result of the Reverse Split. In the event the proposed Reverse Split leaves a shareholder with a fraction of a share, the number of shares due to the shareholder shall be rounded up. For example, if the proposed Reverse Split leaves an individual shareholder with one and one half shares, the shareholder will be issued, post proposed Reverse Split, two whole shares.”

 

SECOND: That thereafter, pursuant to resolution of its Board of Directors, a special meeting of the stockholders of the Corporation was duly called and held upon notice in accordance with section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.

 

THIRD: That said Amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

FOURTH:    That the capital of said Corporation shall not be reduced under or by reason of said Amendment.

 

 

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of the Certificate of Incorporation of CNS Response, Inc. as of March 29, 2012.

 

CNS RESPONSE, INC.  
     
By: /s/ George Carpenter  
Name: George C. Carpenter IV  
Title: CEO  

 

 C: 
 4 

 

 

CERTIFICATE OF OWNERSHIP AND MERGER

MERGING

CNS RESPONSE, INC.,

(A DELAWARE CORPORATION)

WITH AND INTO

STRATIVATION, INC.,

(A DELAWARE CORPORATION)

(UNDER SECTION 253 OF THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE)

 

The undersigned, on behalf of Strativation, Inc., a corporation duly organized and existing under the laws of the State of Delaware:

 

DOES HEREBY CERTIFY:

 

FIRST: Strativation, Inc. (the “COMPANY”), was incorporated on the 20th day of March, 1987 pursuant to the General Corporation Law of the State of Delaware (the “DGCL”), the provisions of which permit the merger of one or more subsidiary corporations organized and existing under the laws of said State into a parent corporation organized and existing under the laws of said State.

 

SECOND: The Company owns 100% of the issued and outstanding shares of the common stock of CNS Response, Inc. (“MergerCo”), a corporation incorporated on the 19th day of January, 2007 pursuant to the DGCL, and having no class of stock outstanding other than such common stock.

 

THIRD: That the Company, by the following resolutions adopted by its Board of Directors, duly adopted by unanimous written consent of the members thereof on February 2, 2007, determined to merge MergerCo into itself, effective as set forth below:

 

WHEREAS, the Company lawfully owns 100% of the issued and outstanding shares of the common stock of CNS Response, Inc., a Delaware corporation (“MERGERCO”);

 

WHEREAS, MergerCo has no class of stock outstanding other than common stock; and

 

WHEREAS, there has been presented a form of Certificate of Ownership and Merger, and certain other agreements and other writings (collectively, the “MERGER DOCUMENTS”) to accomplish the merger of MergerCo into the Company pursuant to Section 253 of the General Corporation Law of the State of Delaware (“MERGER”);

 

WHEREAS, pursuant to the Merger, the separate existence of MergerCo shall cease, the outstanding capital stock of MergerCo shall be cancelled, and the Company shall assume of all of the obligations and liabilities of MergerCo and shall be subject to all the debts and liabilities of MergerCo in the same manner as if the Company had itself incurred them, and each share of the capital stock of the Company shall remain outstanding and unaffected; and

 

WHEREAS, upon the effective date of the Merger, the Company shall relinquish its corporate name and assume in its place thereof the name of MergerCo, which is “CNS Response, Inc.” (“NAME CHANGE”);

 

NOW, THEREFORE, BE IT RESOLVED, that the Merger including the Name Change and assumption of all of the obligations and liabilities of MergerCo by the Company and the transactions contemplated under the Merger Documents are hereby adopted and approved;

 

RESOLVED FURTHER, that the forms, terms and provisions of the Merger Documents are hereby adopted and approved;

 

RESOLVED FURTHER, upon the proposed Merger becoming effective and without any action on the part of any holder thereof each outstanding share of the common stock of MergerCo shall be cancelled without consideration therefor;

 

RESOLVED FURTHER, that the officers of the Company, and each of them, are hereby authorized and directed to cause the Company to perform its obligations under the Merger Documents and to consummate the transactions contemplated thereby, including the Name Change;

 

RESOLVED FURTHER, that the officers of the Company, and each of them, are hereby authorized, for and on behalf of the Company, to modify, amend or revise the forms, terms and provisions of the Merger Documents, to execute, deliver and/or file any and all documents, certificates, instruments, agreements and notices, and to perform or cause to be performed any and all acts as may, in their judgment, be necessary or desirable to accomplish the purposes of the foregoing resolutions and the transactions contemplated thereby and the Merger Documents therein approved whether within or without the State of Delaware and any other state necessary, the making of any such modification, amendment or revision, the taking of any such actions and/or the execution, delivery or filing of any such documents or instruments shall be conclusive evidence that the individual making such modification, amendment or revision, taking such action and/or executing, delivering or filing such document or instrument has deemed the same to be necessary or advisable; 

 

 C: 
 5 

 

 

RESOLVED FURTHER, that the officers of the Company, and each of them, are hereby authorized, directed and empowered by and on behalf of the Company to cause any notice required by the securities laws of any state or jurisdiction to be prepared and filed on behalf of the Company with the appropriate securities regulatory agency together with any required consent to service of process and the payment of any requisite fee; and

 

RESOLVED FURTHER, that the actions of the officers and other agents of the Company and each of them, previously taken in connection with the negotiation of the Merger and/or the preparation of the forms, terms and provisions of the Merger Documents are hereby adopted and approved.

 

”FOURTH: That the proposed Merger has been adopted approved, certified, executed and acknowledged by the Company and the board of directors of MergerCo in accordance with the laws of Delaware.

 

FIFTH: The merger is effective upon filing of this Certificate of Ownership and Merger.

 

IN WITNESS WHEREOF, the Company has caused this Certificate to be signed by an authorized officer this 6th day of March, 2007.

 

  STRATIVATION, INC.
  a Delaware corporation
     
  By: /s/ Leonard J. Brandt
    Leonard J. Brandt, President

 

 C: 
 6 

 

 

STATE OF DELAWARE

CERTIFICATE OF AMENDMENT OF

CERTIFICATE OF INCORPORATION

OF STRATIVATION, INC.

 

Strativation, Inc, (the “Corporation”) a corporation organized and existing under and by virtue of the Delaware General Corporation Law (“DGCL”) does hereby certify:

 

FIRST: That the Board of Directors of the Corporation, by the unanimous written consent of its members, filed with the minutes of the Board, adopted resolutions proposing and declaring advisable the following amendments to the Certificate of Incorporation of the Corporation:

 

RESOLVED FURTHER, that to effectuate the Reverse Split, Article Fourth of the Certificate of Incorporation, as amended and in effect on the date hereof (the Certificate of Incorporation), be amended by adding the following paragraphs thereto:

 

“Upon the date that this Certificate of Amendment to the Certificate of Incorporation of the Corporation becomes effective in accordance with the General Corporation Law of the State of Delaware (the “Effective Date”), each fifty (50) shares of common stock, par value $0.001 per share (“Old Common Stock”), of the Corporation issued and outstanding immediately prior to the Effective Date shall be, without any action of the holder thereof, automatically reclassified as and converted into one (1) share of common stock, par value $0.001 per share (“New Common Stock”), of the Corporation,

 

“Notwithstanding the immediately preceding paragraph, no fractional shares of New Common Stock shall be issued to the holders of record of Old Common Stock in connection with the foregoing reclassification of shares of Old Common Stock, and no certificates or scrip representing any such fractional shares shall be issued. In lieu of such fraction of a share, any holder of such fractional share shall be entitled receive one whole share of the New Common Stock.

 

“Each stock certificate that, immediately prior to the Effective Date, represented shares of Old Common Stock shall, from and after the Effective Date, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares of New Common Stock into which the shares of Old Common Stock represented by such certificate shall have been reclassified. A letter of transmittal will provide the means by which each holder of record of a certificate that represented shares of Old Common Stock shall receive, upon surrender of such certificate, a new certificate representing the number of whole shares of New Common Stock into which the shares of Old Common Stock represented by such certificate shall have been reclassified.”

 

SECOND: That in lieu of a meeting and vote of the stockholders of the Corporation, pursuant to Section 228 of the DGCL, a written consent setting forth resolutions approving the amendments set forth above was signed by the holders of outstanding common stock having not less than the minimum number of votes necessary to authorize or take action at a meeting at which all shares entitled to vote thereon were present and voted, and written notice of the adoption and approval of the amendments has been given as provided in Section 228 of the DGCL to every stockholder entitled to such notice.

 

THIRD: That the foregoing amendment of the Certificate of Incorporation was duly adopted in accordance with the provisions of Section 242 of the DGCL.

 

[Remainder of Page Intentionally Left Blank, Signature Page Follows]

 

 C: 
 7 

 

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed on this 29th day of December, 2006.

 

 

  STRATIVATION, INC.
     
  By: /s/ Silas Phillips
    Silas Phillips
    Chief Executive Officer

 

 C: 
 8 

 

 

STATE OF DELAWARE

 

CERTIFICATE OF ADMENDMENT

 

OF CERTIFICATE OF INCORPORATION

 

The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify:FIRST: That at a meeting of the Board of Directors of Salestactix, Inc. resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of said corporation, declaring said amendment to be advisable and calling a meeting of the stockholders of said corporation for consideration thereof. The resolution setting forth the proposed amendment is as

 

follows:

 

RESOLVED, that the Certificate of Incorporation of this corporation be amended by changing the Article thereof numbered “I” so that, as amended, said Article shall be and read as follows:

 

ARTICLE I

 

“The name of this corporation is Strativation, Inc.”

 

SECOND: That thereafter, pursuant to resolution of its Board of Directors, a special meeting of the stockholders of said corporation was duly called and held upon notice in accordance with Section 222 of the General Corporation Law of the State of Delaware at which meeting the necessary number of shares as required by statute were voted in favor of the amendment.

 

THIRD: That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

IN WITNESS WHEREOF, said Corporation has caused this Certificate to be signed by its duly authorized officer, this 7th day of September, 2005.

 

  /s/ SCOTT ABSHER
  Scott W. Absher
  President 

 

 C: 
 9 

 

 

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

OF

AGE RESEARCH, INC.,

a Delaware corporation

 

It is hereby certified that:

 

1.           The name of the corporation (hereinafter called the “Corporation”) is Age Research, Inc.

 

2.           The Certificate of Incorporation of the Corporation is hereby amended as follows:

 

Article I. of the Certificate of Incorporation is hereby amended in its entirety to read as follows:

 

ARTICLE I.

 

“The name of this corporation is SalesTactix, Inc.”

 

3.           The foregoing amendment was adopted in accordance with Section 242 of the General Corporation Law of the State of Delaware.

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed by its duly authorized officer, this 28th day of July, 2004.

 

  /s/ Vincent Michael Keyes, III
  Vincent Michael Keyes, III, President

 

 C: 
 10 

 

 

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

OF

AGE RESEARCH, INC.,

a Delaware corporation

 

It is hereby certified that:

 

1.           The name of the corporation (hereinafter called the “Corporation”) is Age Research, Inc.

 

2.           The Certificate of Incorporation of the Corporation is hereby amended as follows:

 

Article IV of the Certificate of Incorporation is hereby amended in its entirety to read as follows:

 

ARTICLE IV

 

The amount of total authorized capital stock of this Corporation is Seven Hundred Fifty Thousand Dollars ($750,000) divided into 750,000,000 shares of $0.001 par value each. All shares shall be designated as Common Stock. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Company’s Common Stock.

 

Upon the effectiveness of the certificate of amendment to the Certificate of Incorporation containing this sentence (the “Split Effective Date”), shares of the Common Stock issued and outstanding as of the date and time immediately preceding the Split Effective Date shall be automatically changed and reclassified in accordance with an exchange ratio of one newly issued share for each thirty-five outstanding shares of Common Stock. There shall be no fractional shares issued. A holder of record of Common Stock on the Split Effective Date who would otherwise be entitled to a fraction of a share shall have the number of new shares to which they are entitled rounded to the nearest whole number of shares. The number of new shares will be rounded up if the fractional share is equal to or greater than 0.5 and rounded down if the fraction is less than 0.5. No shareholders will receive cash in lieu of fractional shares.

 

3.           The foregoing amendment was adopted in accordance with Section 242 of the General Corporation Law of the State of Delaware.

 

In witness whereof, Richard F. Holt, has caused this Certificate to be signed by its duly authorized officer, this 1st day of June, 2004.

 

  /s/ Richard F. H
  Richard F. Holt, President

 

 C: 
 11 

 

 

CERTIFICATE OF OWNERSHIP AND MERGER

VOLT RESEARCH, INC.

A UTAH CORPORATION

INTO

AGE RESEARCH, INC.

A DELAWARE CORPORATION

 

(Pursuant to the General Corporation Law of the State of Delaware)

 

Certificate of Ownership and Merger dated April 27, 1987, executed by Volt Research, Inc., a Utah corporation, hereinafter referred to as the “Utah Corporation”, and Age Research, Inc., a Delaware corporation, hereinafter referred to as the “Delaware Corporation” and/or “Surviving Corporation”.

 

The Utah Corporation and the Delaware Corporation do hereby certify:

 

1.           The Utah Corporation Organized Pursuant to Utah Law.

 

The Utah Corporation was organized pursuant to the Corporation Law of the State of Utah on July 10, 1984, which law permits the merger of a Utah corporation with a corporation organized under the laws of another state.

 

2.           Ownership of the Delaware Corporation Shares.

 

The Utah Corporation owns all of the issued and outstanding shares of the Delaware Corporation, a corporation incorporated March 20, 1987, pursuant to General Corporation Law of the State of Delaware.

 

3.           Director Approval and Resolutions of the Utah Corporation.

 

On April 27, 1987, the directors of the Utah Corporation, have duly adopted by the unanimous written consent of its members, filed with the minutes of the board, the ‘following resolutions:

 

RESOLVED, that the Utah Corporation shall merge, and it does hereby merge itself into the Delaware Corporation, its wholly owned subsidiary which assumes all of the obligations of the Utah Corporation. Be it

 

FURTHER RESOLVED, that the merger shall be effective upon filing a Certificate of Ownership and Merger with the Secretary of State of Delaware. Be it

 

FURTHER RESOLVED, that the terms and conditions of the merger are as set forth in the Plan and Agreement of Merger.  Be it

 

FURTHER RESOLVED, that the proper officers of the Utah Corporation be, and they hereby are, directed to make and execute a Certificate of Ownership and Merger setting forth a copy of the resolutions to merge itself into the Delaware Corporation and to cause the same to be filed with the Secretary of State of Delaware and a certified copy recorded in the Office of the Recorder of deeds of New Castle County and to do all acts and things whatsoever, whether within or without the State of Delaware, which may be necessary or proper to effect said merger.

 

4.           Shareholder Vote.

 

On April 27, 1987, at a special meeting of shareholders of the Utah Corporation, held pursuant to twenty (20) day notice to shareholders of record, at which a quorum was present in person or by proxy, the majority of the shareholders of the Utah Corporation approved the Plan and Agreement of Merger.

 

5.           Separate Existence; Surviving Corporation.

 

At the effective time of the merger, the separate existence of the Utah Corporation shall cease and the Utah Corporation shall be merged in accordance with the applicable provision of the Utah Business Corporations Act and the General Corporation Law of Delaware, into the Delaware Corporation, which shall be the Surviving Corporation.

 

 C: 
 12 

 

 

6.           Governing Law.

 

The laws which are to govern the Surviving Corporation, the Delaware Corporation, are the laws of the State of Delaware. The Certificate of Incorporation of the Delaware Corporation shall be the Certificate of Incorporation of the Surviving Corporation, the Delaware Corporation, until the same shall be altered or amended in accordance with the laws of the State of Delaware.

 

7.           Directors and Officers.

 

The directors and officers of the Delaware Corporation, at the time of the merger, shall be the directors and officers of the Surviving Corporation and shall be as follows:

 

Martin A. Voet President/Director
Richard F. Holt, Jr. Secretary/Treasurer/Director
Rollin Green, M.D. Director
Roger Green, M.D. Director

 

8.           Effect of Merger. At the effective time of the merger, the Surviving Corporation, the Delaware Corporation, shall retain or succeed to, without other transfer, and shall possess and enjoy all rights, privileges, immunities, powers, purposes and franchises and be subject to all the restrictions, disabilities and duties of each corporation. All property, both real and personal, tangible and intangible and all debts due to either corporation shall be vested in the Surviving Corporation. All debts, liabilities and duties of either corporation shall be the responsibility of and enforceable against the Surviving Corporation as if said debts, liabilities and duties had been incurred or contracted by the Surviving Corporation. 

 

IN WITNESS WHEREOF, this Certificate has been signed by each of the Corporations which are the parties hereto this 27 day of April, 1987.

 

AGE RESEARCH, INC.   VOLT RESEARCH, INC.
a Delaware corporation   a Utah corporation
     
By: /s/ Martin A. Voet   By: /s/ Martin A. Voet
  Martin A. Voet, President     Martin A. Voet, President
     
Attest:   Attest:
     
By: /s/ Richard F. Holt   By: /s/ Richard F. Holt
  Richard F. Holt, Jr.     Richard F. Holt, Jr.
  Secretary     Secretary

 

State of California  )

) ss.

County of Orange  )

 

On the 27 day of April, 1987, personally appeared before me, a Notary Public, Martin A. Voet, the president, and Richard F. Holt, the secretary, of Volt Research, Inc., a Utah corporation, and of Age Research, Inc., a Delaware corporation, who duly acknowledged to me that they executed this Agreement pursuant to a Resolution of the Board of Directors of said corporations and shareholder approval thereof.

 

  /s/ Margaret Howe
  Notary Public
  Residing at Laguna Niguel

 

My Commission expires: 9/30/88

 

 C: 
 13 

 

 

CERTIFICATE OF

INCORPORATION

OF

AGE RESEARCH, INC.

 

ARTICLE I

 

The name of the Corporation is AGE RESEARCH, INC.

 

ARTICLE II

 

The registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, County of New Castle. The registered agent in charge thereof at such address is The Corporation Trust Company.

 

ARTICLE III

 

The nature of the business, and the objects and purposes proposed to be transacted, promoted and carried on, are to do any or all things herein mentioned, as fully and to the same extent as natural persons might or could do, and in any part of the world, viz.:

 

 “The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware.”

 

ARTICLE IV

 

The amount of the total authorized capital stock of this Corporation is One Hundred Thousand Dollars ($100,000) divided into 100,000,000 shares of $.001 par value each. All shares shall be designated as Common Stock. Shareholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Company’s Common Stock.

 

ARTICLE V

 

The name and mailing address of the incorporator of the Company is:

 

Richard F. Holt 26081 Avenida Aeropuerto, Suite E-1
  San Juan Capistrano, CA 92675
   
Martin A. Voet 26081 Avenida Aeropuerto, Suite E-1
  San Juan Capistrano, CA 92675
   
Rollin Green, M.D. 26081 Avenida Aeropuerto, Suite E-1
  San Juan Capistrano, CA 92675

 

ARTICLE VI

 

The powers of the incorporator(s) shall terminate upon the filing of this Certificate of Incorporation, and the names and mailing addresses of the persons to serve as directors until the first- annual meeting of stockholders or until successors are elected and quality are:

 

Name of Director   Mailing Address
     
Richard F. Holt  

26081 Avenida Aeropuerto, Suite E-1

San Juan Capistrano, CA 92675

     
Martin A. Voet  

26081 Avenida Aeropuerto, Suite E-1

San Juan Capistrano, CA 92675

     
Rollin Green, M.D.  

26081 Avenida Aeropuerto, Suite E-1

San Juan Capistrano, CA 92675

 

 C: 
 14 

 

 

The number of members of the Board of Directors shall be fixed from time to time by the Board of Directors. If any vacancy occurs, the remaining directors, by an affirmative vote of a majority thereof, may elect a director to fill the vacancy until the next annual meeting of stockholders.

 

ARTICLE VII

 

No contract or transaction between the Corporation and one or more of its directors or officers, or between the Corporation and any other corporation, partnership, association, or other organization in which one or more of its directors or officers are directors or officers, or have a financial interest, shall be void or voidable solely for this reason, or solely because the director or officer is present at or participates in the meeting of the board of committee thereof which authorizes the contract or transaction, or solely because his or their votes are counted for such purpose, if:

  

1.           The material facts as to his interest and as to the contract or transaction are disclosed or are known to the Board of Directors or the Committee, and the Board or committee in good faith authorizes the contract or transaction by a vote sufficient for such purpose without counting the vote of the interested director or directors; or

 

2.           The material facts as to his interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or

 

3.           The contract or transaction is fair as to the Corporation as of the time it is authorized, approved or ratified, by the Board of Directors, a committee thereof, or the stockholders. Interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or of a committee which authorizes the contract or transaction.

 

ARTICLE VIII

 

The Board of Directors shall have the power to make, adopt, amend or repeal the Bylaws of the Corporation.

 

ARTICLE IX

 

Section 1.             Elimination of Certain Liability of Directors. A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law (iii) under Section 74 of the Delaware General Corporation Law, or (iv) for any transaction from which the director derived an improper personal benefit.

 

 C: 
 15 

 

 

Section 2.             Indemnification and Insurance.

 

(a)         Right to Indemnification. Each person who was or is made a party or is threatened to be made a party or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a “proceeding”), by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the Corporation-to the fullest extent authorized by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than said law permitted the Corporation to provide prior to such amendment), against all expense, liability and loss (including attorney’s fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators; provided, however, that, except as provided in paragraph (b) hereof, the Corporation shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation. The right to indemnification conferred in this Section shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition; provided, however, that, if the Delaware General Corporation Law requires, the payment of such expenses incurred by a director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such person while a director or officer including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall be made only upon delivery to the corporation of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified under this Section or otherwise. The Corporation may, by action of its Board of Directors, provide indemnification to employees and agents of the Corporation with the same scope and effect as the foregoing indemnification of directors and officers. 

 

(b)         Right of Claimant to Bring Suit. If a claim under paragraph (a) of this Section is not paid in full by the Corporation within 30 days after a written claim has been received by the Corporation, the claimant may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the Corporation) that the claimant has not met the standards of conduct which make it permissible under the Delaware General Corporation Law for the Corporation to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard or conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard or conduct.

 

(c)         Non-Exclusivity of Rights. The right to indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred in this Section shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of the Certificate of Incorporation, bylaw, agreement, vote of stockholders or disinterested directors or otherwise.

 

(d)         Insurance. The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the Delaware General Corporation Law.

 

The undersigned, for the purpose of forming a corporation under the laws of the State of Delaware, do make, file and record this certificate, and do certify that the facts stated herein are true; and have executed this Certificate of Incorporation.

 

Dated: 3/17/1987.

 

  /s/ Richard F. Holt
   
  /s/ Martin A. Voet
   
  /s/ Rollin Green, M.D.

 

 C: 
 16 

 

 

 

STATE OF Utah  )

)ss.

COUNTY OF Salt Lake 

 

On the 17th day of March, 1987, personally appeared before me, Richard F. Holt, who being by me first duly sworn, declared that he is the person who signed the foregoing document as an incorporator and that the statements therein contained are true.

 

IN WITNESS WHEREOF, I have hereunto set my

hand and seal this 17th day of March, 1987.

 

/s/ sic., NOTARY PUBLIC  
   
Residing at Salt Lake  
   
My Commission expires: 3/21/07  

 

 C: 
 17 

 

 

STATE OF Utah  )

)ss.

COUNTY OF Salt Lake  )

 

On the 17th day of March, 1987, personally appeared before me, Martin A. Voet, who being by me first duly sworn, declared that he is the person who signed the foregoing document as an incorporator and that the statements therein contained are true.

 

IN WITNESS WHEREOF, I have hereunto set my

hand and seal this 17th day of March, 1987.

 

/s/ A.O. Headman, NOTARY PUBLIC  
Residing at Salt Lake  
My Commission expires: 3/21/07  

 

 C: 
 18 

 

 

STATE OF California  )

)ss.

COUNTY OF Orange  )

 

On the 16th day of March, 1987, personally appeared before me, Rolin Green, M.D., who being by me first duly sworn, declared that he is the person who signed the foregoing document as an incorporator and that the statements therein contained are true.

 

IN WITNESS WHEREOF, I have hereunto set my

hand and seal this 16th day of March, 1987.

 

/s/ sic., NOTARY PUBLIC  
Residing at El Toro, CA  
My Commission expires: 6-2-89  

  

 C: 
 19 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:12/22/168-K
For Period end:9/30/16
9/21/164,  8-K
9/19/164,  8-K
8/24/16
11/2/15
10/28/158-K,  DEF 14A
9/2/15
5/31/133,  4,  8-K
5/23/134,  8-K,  DEF 14A
3/26/138-K
4/2/123,  8-K
3/29/12
2/2/07
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/22  Emmaus Life Sciences, Inc.        10-K       12/31/21   98:18M                                    ActiveDisclosure/FA
 8/10/21  Emmaus Life Sciences, Inc.        10-K/A     12/31/20   92:18M                                    ActiveDisclosure/FA
 5/04/21  Emmaus Life Sciences, Inc.        10-K       12/31/20   97:18M                                    ActiveDisclosure/FA
 1/25/21  Emmaus Life Sciences, Inc.        10-K       12/31/19  121:29M                                    ActiveDisclosure/FA
Top
Filing Submission 0001615774-16-009049   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 9:28:50.1pm ET